Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide6 min read

HealthRx Cost 2026: $39 First Month, Then $125/Month

HealthRx semaglutide is $39 the first month, then $125/month on its monthly plan. How that compares with monthly rivals, and what is inside the price.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • HealthRx's compounded semaglutide is $39 for the first month, then $125/month until canceled; tirzepatide is $39 for the first month, then $199/month (read Nov 18, 2026). Longer plans have a lower monthly price, but the tiers are not shown.
  • The price includes the clinician consult, medication at every dose, free overnight cold-chain shipping and care-team check-ins - no consultation fee, no shipping charge, no insurance.
  • Per month, welludr ($41), embody ($49), altRx ($89) and Medvi's $99 promo are cheaper than HealthRx's $125; the premium buys the best logistics in the ranking.
  • A sensible check: a year on HealthRx's monthly plan is $1,414 for semaglutide, against $588 at embody and $492 at welludr; decide whether overnight delivery is worth the difference.

Read the first-month price correctly

The short answerHealthRx's semaglutide is $39 for the first month, then $125/month until canceled. Tirzepatide is $39, then $199/month. Longer plans have a lower monthly price, but its pages do not show the tiers; the pricing page states "Prices current as of October 15, 2026." The price includes the clinician consult, the medication at every dose, free overnight cold-chain shipping, and ongoing care-team check-ins - no consultation fee, no shipping charge, cash-pay with no insurance.

That matters because $39 is a first-month price, not the monthly price. Twelve months on the monthly plan comes to $1,414 for semaglutide ($39 + 11 x $125). Check the plan terms at checkout; with that in mind, the comparisons get interesting.

The year table - where HealthRx competes

Price a full year of semaglutide at every provider's real rate and structure:

ProviderBillingYear total
welludr$41/mo, 12-mo lock, billed monthly$492
embody$49/mo flat, cancel anytime$588
altRx$89/mo flat, pause anytime$1,068
Medvi$99/mo promo (reg. $199), all-inclusive$1,188
HealthRx$39 first month, then $125/mo, until canceled$1,414
SHED$199/mo + coaching$2,388
DirectMeds$249/mo (sublingual)$2,988

Read honestly: four providers charge less per month than HealthRx's $125, three of them (embody, altRx, Medvi) with no commitment at all. What the extra $26-$84 a month buys at HealthRx is overnight cold-chain delivery on every shipment - the best logistics in the ranking - plus dose-stable pricing and LegitScript-certified fulfillment. That's the real trade: paying a premium over the budget tier for premium shipping, while still below SHED and DirectMeds.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

Longer plans: the question nobody can price

HealthRx says longer plans have a lower monthly price but does not show the tiers, so a long commitment cannot be compared with the rows above. The monthly plan avoids the question: it renews until canceled, by email. A dose change or tolerance issue could reshape your plan - the scenarios covered in how long semaglutide takes to work. A reasonable path: start the monthly plan, or run 2-3 months at a flexible provider (embody, $49 flat) to confirm fit, then ask HealthRx for the longer-plan price before you prepay.

Is HealthRx's tirzepatide competitively priced?

The $199/month tirzepatide tier (after a $39 first month) competes in a different weight class: welludr charges $71, embody $99, altRx $149 and Medvi $166 promotional for the same active ingredient - all billed monthly. HealthRx's tirzepatide case rests on its overnight logistics, not its price. If tirzepatide is your medication and delivery speed isn't your priority, shop that tier first.

→ Full HealthRx review with everything the plan includes

This article is general information, not medical advice. Prices as listed at the time of writing - confirm current terms on the provider's site.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)